Printer-friendly version

HIV in the News

Published on: April 14, 2014

The Guardian Liberty Voice reported on a clinical trial that tested the safety and efficacy of ABT-450, a new oral treatment for hepatitis C virus (HCV) infection. The treatment includes pills taken once daily and some taken twice a day. Current HCV treatment includes the use of interferon, which has ...

Published on: April 14, 2014

2014 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators discuss new findings in Immune System Diseases and Conditions. According to news originating from Boston, Massachusetts, by NewsRx corresponden ...

Published on: April 14, 2014

Immunosuppressant drugs used to prevent rejction of transplanted organs may combat the HIV reservoir.

Published on: April 11, 2014
Published on: April 11, 2014

Science Codex reported that according to the Global Burden of Disease Study 2010 (GBD 2010), viral hepatitis has a mortality rate 10 times that of HIV/AIDS among European Union (EU) countries. Viral hepatitis, which includes hepatitis C virus (HCV) and hepatitis B virus (HBV), was blamed for nearly 90,000 ...

Published on: April 11, 2014

WSIL-TV reported that 2012 statistics from Illinois’s Jackson County Health Department demonstrate a rise in STDs in the southern area of the state. Reported gonorrhea cases were 64 percent higher in the county than the state average, and more than double the average rate for the United States. Chlamydia ...

Published on: April 11, 2014

The Kittanning Paper reported that Breathe Pennsylvania is hosting a free TB educational conference on April 25 from 8:00 a.m. to noon at the Pittsburgh Athletic Association located at 4215 Fifth Avenue. According to Joan McMahon, RN, MPH, TB educator at Breathe Pennsylvania, the organization wants to ...

Published on: April 11, 2014

The San Jose Mercury News reported that a court order is being sought to prevent an infectious TB patient from leaving his home and spreading the disease to others in central Illinois. A state health official is asking a judge to force the uncooperative patient to wear an electronic monitoring ankle bracelet ...

Published on: April 11, 2014

AIDSMEDS reported on a study to determine the effects of perceived pressure, perceived efficacy, and fear and anxiety on retaining young people in HIV prevention interventions. The researchers evaluated the 386 young adults ages 18–35 participating in a multi-session HIV prevention intervention in Duval ...

Published on: April 11, 2014
From AIDSinfo

“On April 8, 2014 FDA approved updates to the Isentress (raltegravir) label to include information regarding co-adminsitration of raltegravir with boceprevir or telaprevir.

“In drug interaction studies, raltegravir did not have a clinically meaningful effect on the pharmacokinetics of telaprevir or boceprevir. No dose adjustment is required for Isentress or boceprevir or telaprevir.”

Funded By: